Bone health
Forteo — References & further reading
1 Quattrochi, E., & Kourlas, H. 2004. Teriparatide: A review. Clin. Ther., 26 (6), 841–854. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15262455 (accessed 05.18.2009).
2 Eli Lilly Canada, Inc. 2008. Forteo, Product Monograph. Toronto, Ontario: Eli Lilly Canada.
3 Eastell, R., et al. 2009. Sequential treatment of severe postmenopausal osteoporosis after teriparatide: Final results of the randomized, controlled European study of Forteo (EUROFORS). J. Bone Miner. Res., 24 (4), 726–736. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19049337 (accessed 05.18.2009).
4 Vahle, J., et al. 2002. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1–34) for 2 years and relevance to human safety. Toxicol. Pathol., 30 (3), 312–321. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/12051548 (accessed 05.18.2009).
5 Hodsman, A., et al. 2005. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr. Rev., 26 (5), 688–703. URL: http://edrv.endojournals.org/cgi/reprint/26/5/688 (accessed 05.18.2009).
6 Eli Lilly Canada, Inc. 2008. Forteo, Product Monograph, Eli Lilly Canada, Toronto, Ontario.
7 Eli Lilly and Company. 2008. Forteo teriparatide (rDNA origin) injection. PDF available here: http://pi.lilly.com/us/forteo-pi.pdf (accessed 05.13.2009).
8 Eastell, R., et al. 2009. Sequential treatment of severe postmenopausal osteoporosis after teriparatide: Final results of the randomized, controlled European study of Forteo (EUROFORS). J. Bone Miner. Res., 24 (4), 726–736. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/19049337 (accessed 05.18.2009).
9 Dobnig, H. 2004. A review of teriparatide and its clinical efficacy in the treatment of osteoporosis.
Expert Opin. Pharmacother, 5 (5), 1153–1162. URL (abstract):
http://www.ncbi.nlm.nih.gov/pubmed/15155114 (accessed 05.18.2009).
Return to:
Forteo — too good to be true?
Original Publication Date: 07/01/2009
Last Modified: 08/17/2009
Principal Author: Marcella Sweet